Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney

Kidney International

Volumn 66, Issue 2, 2004, Pages 633-640

  Narkar, Vihang ^a   Kunduzoa, Oksana ^c   Hussain, Tahir ^c   Cambon, Claudie ^c   Parini, Angelo ^c   Lokhandwala, Mustafa ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c NONE

Author keywords

Bromocriptine; Ischemia reperfusion injury; Kidney; p44 42 MAPK

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BROMOCRIPTINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; RAT STRAIN; RENAL PROTECTION; REPERFUSION INJURY; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; KIDNEY CORTEX; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BROMOCRIPTINE; DOPAMINE AGONISTS; KIDNEY CORTEX; KIDNEY DISEASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NA(+)-K(+)-EXCHANGING ATPASE; NECROSIS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; REPERFUSION INJURY;

EID: 3242803680     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00783.x     Document Type: Article

References (43)

1. CHIAO H, KOHDA Y, MCLEROY P, et al: Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165-1172, 1997
2. + transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 278:F925-F939, 2000
3. MASHIACH E, SELA S, WINAVER J, et al: Renal ischemia-reperfusion injury: Contribution of nitric oxide and renal blood flow. Nephron 80:458-467, 1998
4. PARK KM, CHEN A, BONVENTRE JV: Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38 and MAPKs kinase activation by remote ischemic pretreatment. J Biol Chem 276:11870-11876, 2001
5. PARK KM, KRAMERS C, VAYSSIER-TAUSSAT M, et al: Prevention of kidney ischemia/reperfusion-induced functional injury, MAPKs and MAPKs kinase activation, and inflammation by remote transient urethral obstruction. J Biol Chem 277:2040-2049, 2002
6. BONEGIO R, LIEBERTHAL W: Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301-308, 2002
7. GOBE G, WILLGOSS D, HOGG N, et al: Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 56:1299-1304, 1999
8. PADANILAM BJ: Cell death induced by acute renal injury: A perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284:F608-F627, 2003
9. BREZIS M, ROSEN S, SILVA P: Renal ischemia: A new perspective. Kidney Int 26(4):375-383, 1984
10. Di MARI JF, DAVIS R, SAFIRSTEIN RL: MAPKs activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 277:F195-F203, 1999
11. VENKATACHALAM MA, BERNARD DB, DONOHOE JF, et al: Ischemic damage and repair in the rat proximal tubule: Differences among the S1, S2, and S3 segments. Kidney 14(1):31-49, 1978
12. BRADY HR, BRENNER BM, LIEBERTHAL WL: Acute renal failure, in The Kidney, 1986, pp 1200-1257, 1986
13. BONVENTRE JV: Mediators of ischemic renal injury. Ann Rev Med 39:531-544, 1988
14. RACUSEN LC: The morphological basis of acute renal failure, in Acute Renal Failure 2001, pp 1-12
15. ABE J, BAINES CP, BERK BC: Role of mitogen-activated protein kinases in ischemia and reperfusion injury. Circ Res 86:607-609, 2000
16. YUE TL, WANG C, GU JL, et al: Inhibition of extracellular signal-regulated kinase enhances ischemia-reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86:692-699, 2000
17. KUNDUZOVA OR, BIANCHI P, PIZZINAT N, et al: Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 16:1129-1131, 2002
18. XIA Z, DICKENS M, RAINGEAUD J, et al: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995
19. HUSSAIN T, LOKHANDWALA MF: Renal dopamine receptors and hypertension. Exp Biol Med 228:134-142, 2003
20. JOSE PA, EISNER GM, FELDER RA: Dopamine receptors in health and hypertension. Pharmacol Ther 80:149-182, 1998
21. 2 receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 12:1844-1852, 2001
22. +,ATPase in kidney. Am J Physiol: Renal Physiol 282:F697-F702, 2002
23. KUNDUZOVA OR, BIANCHI P, PIZZINAT N, et al: Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 16:1129-1131, 2002
24. +-ATPaSe activity induced by ischemia/reperfusion injury in canine kidney. Nephron 72:637-643, 1996
25. +,ATPase activity of rabbit kidney cortex membranes in ischemia and reperfusion. Acta Biochem Pol 40:545-547, 1993
26. FEKETE A, VANNAY A, VER A, et al: Gender differences in the alterations of Na+/K+-ATPase following ischemia/reperfusion injury in the rat kidney. J Physiol (Lond) 2003
27. WANG Z, RABB H, HAQ M: A possible molecular basis of natriuresis during ischemic-reperfusion injury in the kidney. J Am Soc Nephrol 9(4):605-613, 1998
28. +,ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol 321:259-263, 1997
29. +,ATPase α1-subunits in kidney. Am J Physiol Renal Physiol 283:F1290-F1295, 2002
30. DIMARI J, MEGYESI J, UDVARHELYI N, et al: N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 272:F292-F298, 1997
31. MEHTA A, SEKHON CP, GIRI S, et al: Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon. Mol Cell Biochem 240:19-29, 2002
32. YANG CW, LI C, JUNG JY, et al: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17:1754-1755, 2003
33. YANG CW, AHN HJ, JUNG JY, et al: Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation 75:20-24, 2003
34. MARTINEZ-MIER G, TOLEDO-PEREYRA LH, MCDUFFIE JE, et al: Exogenous nitric oxide downregulates MIP-2 and MIP-1alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg 15:287-296, 2002
35. 2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J Neurosci Res 70:274-282, 2002
36. LIU XH, KATO H, CHEN T, et al: Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J Neurol Sci 29:9-14, 1995
37. 2 receptor agonists protect against ischemia-induced hippocampal neurodegeneration in global cerebral ischemia. Eur J Pharmacol 352:37-46, 1998
38. TISSARI AH, LILLGÄLS MS: Reduction of dopamine synthesis inhibition by dopamine auto-receptor activation in striatal synaptosomes with in vivo reserpine administration. J Neurochem 61:231-238, 1993
39. GLOVER V, CLOW A, SANDLER M: Effects of dopaminergic drugs on superoxide dismutase: Implications for senescence. J Neural Transm 40 (Suppl):37-45, 1993
40. TAGAYA M, MATSUMOTO M, KITAGAWA K: Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils. Life Sci 51:253-259, 1992
41. WENGENACK TM, CURRAN GL, PODUSLO JF: Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res 754:46-54, 1997
42. YOSHIKAWA T: Free radicals and their scavengers in Parkinson's disease. Eur Neurol 33:60-68, 1993
43. YOSHIKAWA T, MINAMIYAMA Y, NAITO Y, et al: The antioxidant properties of dopamine agonist bromocriptine. J Neurochem 62:1034-1038, 1994